There are silver linings I suppose to Medipharm's PPS. My shares are stuck. Can't inject any more to further reduce my cost basis without "signs-of-life".
Medipharm just looks dead in the water until they get more EU approvals. That could take another 6 - 12 months, if ever.
Expect another capital raise before then to keep the lights on. That's the definition of "bad dilution".
New money on dips at the other extractor is the better play.
News 
Market Data 
Discover 
